TMPRSS2-ERG Fusion Protein Expression - CISMeF

" /> TMPRSS2-ERG Fusion Protein Expression - CISMeF

CISMeF

chu

TMPRSS2-ERG Fusion Protein ExpressionNCIt concept

Preferred Label : TMPRSS2-ERG Fusion Protein Expression;

Details

Origin ID

C82365;

UMLS CUI

C2826126;

Molecular abnormality of diseases
- Advanced Prostate Adenocarcinoma [NCIt concept]
- Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Advanced Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Aggressive Prostate Adenocarcinoma [NCIt concept]
- Grade II Prostatic Intraepithelial Neoplasia [NCIt concept]
- Grade III Prostatic Intraepithelial Neoplasia [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant [NCIt concept]
- Invasive Prostate Carcinoma [NCIt concept]
- Localized Prostate Adenocarcinoma [NCIt concept]
- Locally Advanced Prostate Adenocarcinoma [NCIt concept]
- Locally Advanced Prostate Neuroendocrine Carcinoma [NCIt concept]
- Locally Advanced Unresectable Prostate Adenocarcinoma [NCIt concept]
- Metastatic Prostate Adenocarcinoma [NCIt concept]
- Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Metastatic Prostate Neuroendocrine Carcinoma [NCIt concept]
- Metastatic Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Moderately Differentiated Prostate Adenocarcinoma [NCIt concept]
- Poorly Differentiated Prostate Adenocarcinoma [NCIt concept]
- Prostate Acinar Adenocarcinoma [NCIt concept]
- Prostate Acinar Adenocarcinoma, Atrophic Pattern [NCIt concept]
- Prostate Acinar Foamy Gland Adenocarcinoma [NCIt concept]
- Prostate Acinar Lymphoepithelioma-Like Adenocarcinoma [NCIt concept]
- Prostate Acinar Microcystic Adenocarcinoma [NCIt concept]
- Prostate Acinar Mucinous Adenocarcinoma [NCIt concept]
- Prostate Acinar Oncocytic Adenocarcinoma [NCIt concept]
- Prostate Acinar Pleomorphic Giant Cell Adenocarcinoma [NCIt concept]
- Prostate Acinar Pseudohyperplastic Adenocarcinoma [NCIt concept]
- Prostate Acinar Sarcomatoid Carcinoma [NCIt concept]
- Prostate Acinar Signet Ring Cell-Like Adenocarcinoma [NCIt concept]
- Prostate Adenocarcinoma [NCIt concept]
- Prostate Adenocarcinoma by AJCC v7 Stage [NCIt concept]
- Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation [NCIt concept]
- Prostate Adenocarcinoma without Neuroendocrine Differentiation [NCIt concept]
- Prostate Adenoid Cystic Carcinoma [NCIt concept]
- Prostate Adenosquamous Carcinoma [NCIt concept]
- Prostate Basal Cell Carcinoma [NCIt concept]
- Prostate Ductal Adenocarcinoma [NCIt concept]
- Prostate Ductal Adenocarcinoma, Cribriform Pattern [NCIt concept]
- Prostate Ductal Adenocarcinoma, Papillary Pattern [NCIt concept]
- Prostate Ductal Adenocarcinoma, Solid Pattern [NCIt concept]
- Prostate Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Prostate Neuroendocrine Carcinoma [NCIt concept]
- Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Prostate Squamous Cell Carcinoma [NCIt concept]
- Prostate Undifferentiated Carcinoma [NCIt concept]
- Prostatic Intraepithelial Neoplasia-Like Adenocarcinoma [NCIt concept]
- Recurrent Prostate Acinar Adenocarcinoma [NCIt concept]
- Recurrent Prostate Adenocarcinoma [NCIt concept]
- Recurrent Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Refractory Prostate Adenocarcinoma [NCIt concept]
- Refractory Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Stage I Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage II Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage III Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Stage IV Prostate Adenocarcinoma AJCC v7 [NCIt concept]
- Treatment-Related Prostate Neuroendocrine Carcinoma [NCIt concept]
- Unresectable Prostate Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Well Differentiated Prostate Adenocarcinoma [NCIt concept]
Semantic type(s)
- Cell or Molecular Dysfunction [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
14/05/2024

© Rouen University Hospital. Any partial or total use of this material must mention the source.